Regeneron, the Roche antibody cocktail, reduces COVID-19 hospitalizations and deaths by 70%
A combined monoclonal antibody cocktail produced by Regeneron and Roche has been shown to reduce hospitalization or death in patients with COVID-19 by up to 70%, a press release published on Tuesda…
